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Nitrous acid (HNO2) is the major gas-
phase acid in environmental tobacco smoke
(1) and in its vapor phase is found in auto-
mobile emissions. Although outdoor ambi-
ent concentrations are less than those ofsul-
furic acid (H2SO4) and nitric acid
(HNO3), up to 8 ppb HNO2 has been
measured in ambient air in California dur-
ing an air pollution episode (2). In homes
with combustion sources, elevated HNO2
levels may be associated with direct emis-
sions from the source as well as with reac-
tions of emitted NO2 with water vapor in
air. Indoor concentrations of HNO2 are
higher than outdoor concentrations, even
when indoor concentrations ofNO2 do not
exceed outdoor levels. Peak levels ofHNO2
may exceed 50 ppb and persist for several
hours (3,4). Nitrous acid may also be a sec-
ondary reaction product ofNO2 with water
on indoor surfaces and, under experimental
conditions, has been found to make up as
much as 10% ofoxides ofnitrogen after an
interval ofreaction (5). Conventional assays
ofNO2 measure several oxides ofnitrogen
together, including HNO2. For this reason,
previous studies of respiratory effects of
indoor NO2 may have induded exposures
to HNO2 without independent measure-
ment ofexposure and effect (6).
Based on in vitro studies, it has been
postulated that at environmental concen-
trations HNO2 is formed within the respi-
ratory system predominantly by hydrogen
abstraction (2), with subsequent conversion
of HNO2, at physiologic pH, to H+, and
NO2- (2). It has been proposed that HNO2
formed in this way may contribute to the
bronchoconstricting effects ofNO2 seen in
normal subjects and asthmatics. Studies of
the direct effects of HNO2 on the human
respiratory system are thus of interest
because exposures may occur from primary
indoor and outdoor sources or from reac-
tion products of NO2 formed within the
human respiratory system. A need for more
information on the health effects ofHNO2
has recentlybeen identified (8).
We performed a chamber exposure
study to determine whether there is an
effect on respiratory symptoms or lung
mechanics in a group of patients (mild
asthmatics) who have been demonstrated
in some but not all studies to be sensitive
to other acid species (9L12). We used a
concentration of HNO2 higher than that
usually measured in homes with unvented
combustion sources (4), but the duration
ofexposure was shorter than may occur in
such homes.
Methods
Subjects. The protocol was approved by the
Yale University School of Medicine
Human Investigations Committee, and all
subjects gave informed consent to partici-
pate. The 11 subjects were recruited by
advertisements and were selected using the
following inclusion criteria: age between 18
and 40 years, nonsmoking, and in good
general health other than mild asthma (as
defined by a physician's diagnosis with typ-
ical symptoms and occasional but not regu-
lar use of bronchodilator medications). In
addition to these criteria, all subjects had
baseline forced expiratory volume in 1 sec
(FEVy) and forced vital capacity (FVC)
within the normal range for age, sex, and
height (13) and had methacholine reactivi-
ty within the asthmatic range [a provoca-
tive concentration (PC) of methacholine
less than 8 mg/mL causing a 20% fall in
FEVI excepting subject 2, whose PC20 was
26 mg/mL]. Exclusion criteria included
regular or current use of bronchodilator
medications, current active asthma symp-
toms, presence of wheezing on physical
exam, or inability to comfortably perform
moderate cycle exercise for 20 min.
Subjects did not need or use asthma med-
ications during the days before or during
the chamber studies. Once accepted into
the study, subjects had a training session
with spirometry and a cycle ergometer
exercise session during which a workload
tolerable for 20 min was determined.
Protocol. Each subject underwent two
3-hr intermittent exercise chamber expo-
sures which differed only in that one was
conducted with continuous HNO2 expo-
sure at a target level of700 ppm, while the
other was conducted with filtered, clean
air. Air temperature was maintained at
18°C during exposure to provide a com-
fortable ambient environment for sustained
moderate exercise. The 3-hr chamber exer-
cise periods were performed in a balanced,
randomized double-blinded crossover
design, so that six subjects were exposed to
HNO2 on their first test day and five to
clean air. Exposures were separated by a 1-
to 2-week washout period. Subjects and
investigators (who entered the chamber
with subjects to perform measurements of
exercise responses and resting lung
mechanics) were blinded as to whether
exposure was to HNO2 or to clean air. The
effectiveness ofthe blinding procedure was
assessed by asking subjects and investiga-
tors to indicate, at the end ofeach exposure
session, whether they believed exposure
had been to HNO2 or clean air.
During each 3-hr exposure, subjects
completed a baseline symptom question-
naire and spirometry immediately on
entering the chamber, and then 20 min of
cycle ergometer exercise at their predeter-
mined constant workload at the start of
each hour. Heart rate (HR) (Polar Electro
Inc., Heartland, Wisconsin), minute venti-
lation (VE), and tidal volume (VT) (5410
volume meter, Ohmeda, Englewood
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Colorado, calibrated with a Tissot spirom-
eter) were measured at 5, 10, and 15 min
of each exercise period. Immediately after
exercise, subjects completed the symptom
questionnaire, and then performed spirom-
etry within the chamber 5 min later (Eagle
II Stead Wells survey spirometer, W.E.
Collins Inc., Braintree, Massachusetts).
American Thoracic Society criteria for
standardization ofspirometry were applied
(14). Subjects then rested in a seated posi-
tion within the chamber until the next
exercise session. A final spirometry and
questionnaire were completed at the end of
180 min, just before leaving the chamber.
Symptoms. Subjects completed the
same symptom questionnaire five times
over each exposure session. They rated
each symptom by placing a mark on a 10-
cm continuous line representing a score of
"absent" through "the most severe ever
experienced." Four respiratory symptoms
(shortness of breath, wheeze, cough, chest
tightness), six sensory irritant questions
(skin irritation, eye irritation, eye tearing,
throat irritation, nasal stuffiness, nasal dry-
ness), and one negative control question
(headache) were induded.
Generation ofHNO2. Nitrous acid was
generated by a reaction of sodium nitrite
with sulfuric acid using the method of
Taira and Kanda (15). A solution of 0.08
M sulfuric acid and a solution of 0.06 M
sodium nitrite were prepared with distilled
deionized water. A peristaltic pump added
each of the solutions at 2 ml/min onto a
circular piece of fritted glass, which was
located near the base ofthe reaction cham-
ber. Ambient air was filtered through a sys-
tem of Purafil (potassium permanganate-
coated aluminum) and activated charcoal
and passed into the reaction chamber
below the glass frit at 20 L/min. The
cleaned air passed through the glass frit
and bubbled through the reagent mixture,
removing HNO2 from the solution. The
mixture was passed through a condensing
chamber to remove excess water vapor.
This HNO2-containing gas was then fed
into the exposure chamber. Excess reagent
was removed from the reaction chamber by
three tubes located 8 mm above the
reagent inlet, and connected to a vacuum
flaskand avacuum pump.
Measurement ofHNO2. We moni-
tored the nitrous acid concentration in the
chamber air by a continuous method using
a chemiluminescent NOX analyzer with a
system of filters and a valve. Two filter
packs were set up in parallel to the NOX
analyzer inlet, with a valve switching from
one filter pack to the other every 2 min.
One filter packcontained aglass-fiber filter
coated with sodium carbonate and glyc-
erol, and the other contained an uncoated
filter. The coated filter removed the
HNO2 from the air passing through it,
while allowing the NO and NO2 to pass
through. The uncoated filter did not
remove any of these gases. The NOX ana-
lyzer measured HNO2 as the difference in
signal with andwithout the coated filter.
We also used a noncontinuous method
of measuring HNO2 employing the
Harvard EPA Annular Denuder System
(16) with two denuders in series sampling
at 4 L/min. In this system the sample air
passed through the space between concen-
tric glass tubes (the annular denuder),
which was coated with sodium carbonate
and glycerol. Nitrous acid diffused to the
coated walls and was trapped, while
nonacidic gases passed through uncollect-
ed. The denuders were extracted with
ultra-pure water after the sampling period.
The concentration of nitrite ion in the
denuder extract was measured by ion chro-
matography to allow determination of the
total amount of nitrous acid that passed
through the denuder system. The chamber
HNO2 concentration was then calculated
from this value. The chamber size was 18
m3 (624 ft3), and the ventilation rate aver-
aged approximately 30 ft3/min, or three air
changes per hour.
Statisticalanalysis. To ensure compara-
ble baseline pulmonary function at the start
ofeach session, we compared the two pre-
exercise spirometry readings using a paired
t-test. The effects ofHNO2 exposure, time,
and their interactive influence upon exer-
cise and spirometry measurements were
evaluated with repeated measures analysis
ofvariance. We analyzed spirometry results
with actual values and expressed them as
percent predicted (13). Symptom scores for
each symptom of the four questionnaires
completed 20, 80, 140, and 180 min after
entering the chamber were combined as a
mean score, and results from the exposure
day compared with clean air by the
Wilcoxon signed-rank sum test (17). For all
analyses, a two-sided significance level was
chosen at p <0.05. Due to equipment fail-
ure, minute ventilation, tidal volume, and
respiratory rate were not obtained for one
subject at a single time point. For purposes
of statistical analysis, this subject's data
were deleted at all time points. Data were
analyzed using Systat statistical software
(Systat Inc., Evanston, Illinois).
Results
All 11 subjects selected for inclusion in the
study completed the protocol. Subject
characteristics are listed in Table 1, along
with the ergometer workload and minute
ventilation established during the practice
session. The mean HNO2 concentration
and standard deviation within the chamber
on exposure days was 648 ± 41 ppb.
(Measurements of HNO2 were not made
in the homes ofsubjects).
Subjects were successfully blinded as to
exposure conditions, in that they correctly
identified the chamber exposure condi-
tions of only 27% of the sessions. The
investigators were also successfully blind-
ed, identifying exposure correctly in 60%
ofthe sessions (which was not significantly
different from an expected 50%; 95% CI,
39-81%).
Results of serial spirometry during
HNO2 control and exposure days are
shown in Figure 1. Baseline values were
not different at the beginning of control
and exposure days, but there was a statisti-
cally significant decrease in FVC during
HNO2 exposure which was most marked
at 25 min after the beginning of exposure
and persisted throughout the 3-hr exposure
(p = 0.017 when vital capacity expressed as
absolute value; p = 0.020 when vital capac-
ity expressed as percent predicted). The
Table 1. Characteristics of mildly asthmatic subjects and workload set during exercise
Minute
Age Work ventilation
Subject no. (years) Sex Height FEVJ (%) FVC (%)a PC20b (kpm/min) (L/min)
1 28 F 160 3.10(104) 3.60(97) 0.6 360 35
2 24 F 169 3.79(110) 4.64(108) 26 180 23
3 23 M 173 3.71 (87) 4.53 (86) 4 540 34
4 38 F 171 3.35 (109) 4.25(108) 8 270 32
5 26 F 156 2.79(98) 3.09(87) 2 360 31
6 28 M 172 3.34(81)' 4.73(92) 1 450 48
7 27 F 157 2.94(101) 3.59(99) 2 450 33
8 35 M 164 3.92 (109) 4.65 (103) 2 630 39
9 39 F 164 2.91 (101) 3.16 (86) 0.2 540 25
10 30 F 157 2.60 (92) 3.26 (92) 0.7 360 36
11 18 M 167 3.75(88) 4.00(79) 3 540 30
Mean 29 165 3.29 (98) 3.95(94) 4.5 425 33
SD 7 6 0.45(9) 0.64 (10) 7.5 134 7
SE 2 2 0.14(3) 0.19(3) 2.25 40 10
Abbreviations: FEV1, forced expiratory volume in 1 sec; FVC, forced vital capacity; kpm, kilopond-meters.
aPredicted normal values from Morris et al.(13).
bPC FEV methacholine: the provocative concentration of inhaled methacholine chloride, causing a 20%
decline from the baseline FEVJ.
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FVC was small: at 25 min the mean differ-
ence was 108 mL, representing a mean dif-
ference of approximately 3% between
exposure and control conditions. Mean
values of FEV1 were also not different at
the beginning of control or exposure ses-
sions, and no effect of HNO2 exposure
was seen on expiratory airflow at the begin-
ning of expiration (FEV1) or during mid-
flow (MMEF, maximal mid-expiratory
flow rate). Although the controlled design
of this study permitted evaluation of exer-
cise-induced bronchospasm independently
of any effect of HNO2 exposure, little
exercise-induced bronchospasm was seen
in this group ofmild asthmatics. The max-
imum mean FEV1 decline from pre-exer-
cise baseline was 32 mL on the control
days and 39 mL on the exposure days, rep-
resenting an approximately 1% post-exer-
cise decline. Because spirometry was per-
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Figure 1. Mean forced vital capaci
forced expiratory volume in the fin
expiration (FEV1) for 11 subjects juw
start of the chamber sessions and a
and 180 min of exposure (bars repres
mean). Vital capacity on HNO2 expos
significantly lowerthan on control da
formed 5 min after exercise, delayed exer-
cise-induced bronchospasm, which may be
maximal more than 5 min after the end of
exercise, may not have been detected.
Serial measures of heart rate, minute
ventilation, tidal volume, and breathing
frequency on control and exposure days are
shown in Table 2. Comparison showed no
statistically significant effects of HNO2
exposure on these responses to exercise.
The comparable values of HR and VE
under the two exposure conditions indicate
comparable exercise workloads and cardio-
vascular and ventilatory responses on con-
trol and exposure days.
Mean symptom scores reported during
exposure were low under both control and
exposure conditions, ranging from 0.0 to
1.0 on a 10-point scale (Table 3). As
reflected in the successful blinding, the sub-
jects were uncertain as to whether exposure
sessions were to HNO2 or clean air.
However, the aggregate score ofall 10 test
symptoms was higher on the HNO2 than
control days. This difference was small but
statistically significant (p = 0.038). The dif-
ference between the mean score on expo-
sure and control days for the negative con-
trol symptom (headache) was lower than
for seven other symptoms and identical to
that forwheeze, cough, and nasal stuffiness.
Discussion
Nitrous acid at 650 ppb over a 3-hr expo-
sure period is a weak sensory irritant, as
demonstrated by the failure of subjects to
distinguish exposure from control days.
Control Nonetheless, a physiologic effect of expo-
INO sure was detectable with this concentration
2 and duration, as seen in the alteration ofsta-
ticlung mechanics in these mildlyasthmatic
140 in0 subjects. The small, statistically significant
effect on FVC in the absence ofan effect on
FEV1 or MMEF suggests that the expo-
ity (FVC) and sure-duration combination used in this
st second of study is above, but not far, from the thresh-
st before the old for effects on lung mechanics. The pri- it 2, 85, 14,
;ent SE ofthe mary response at this dose, a reduction in
ure days was vital capacity, may be due either to inhibi-
lys. tion of maximal inspiratory effort, a reduc-
tion in respiratory system compliance, or
closure of airways at higher lung volumes.
However, because of the solubility of
HNO2 in airway mucosal water and the rel-
atively low concentration tested, it is likely
that most of the vapor is absorbed in the
respiratory mucosa before reaching terminal
bronchioles and alveoli. For this reason, we
speculate that the mechanism for this effect
is inhibition of maximal inspiration due to
effects on sensory afferent nerves. This
mechanism has been demonstrated for
ozone, a potent respiratory irritant, at 500
ppb (18). However, because ozone is an
aqueous, insoluble gas which is poorly
absorbed in the upper airways and HNO2
would be expected to be well absorbed in
the upper airways, these data raise the possi-
bility that the effect seen was due to stimu-
lation ofupper airway receptors, having the
effect ofinhibitingmaximal inspiration.
Asthmatic subjects were chosen for this
study as a potentially more sensitive clinical
group. Because only asthmatics were stud-
ied, we do not knowwhether nonasthmatic
subjects are less susceptible, or more severe
asthmatics are more susceptible, to this
concentration and duration ofexposure.
Nitrous acid is ofinterest as an environ-
mental exposure due to its presence in
emissions from automobiles, natural gas
and kerosene-burning appliances, and envi-
ronmental tobacco smoke. It may also be a
reaction product of inhaled NO or NO2
within the respiratory system. Still, little
information is available on respiratory sys-
tem effects of nitrous acid alone. An in
vitrostudy has demonstrated that HNO2 is
capable offunctionally inactivating human
plasma a-I proteinase inhibitor in a 0.05
M sodium acetate buffer solution when
incubated for 15 min at 25°C, pH 4.0.
(19). Two studies have suggested, on the
basis of in vitro simulations and studies in
isolated perfused rat lungs, that inhaled
NO2 undergoes nonsaturable uptake or
transformation in the lung, forming low
molecular weight soluble reaction products,
the predominant one being HNO2. Using
cyclo-hexane to simulate lung lipid with in
Table 2. Exercise parameters (means ± SEM) during control and HNO2 exposure daysa
Time (min)
5 10 15 65 70 75 125 130 135
HR Control 126±4 130±5 135±5 125±5 126±4 132±5 128±5 133±5 135±6
HNO2 131±4 133±5 135±4 127±4 132±4 136±4 132±5 134±3 136±4
VE(L/min) Control 33±2 34±2 34±2 31±2 32±2 33±2 32±2 34±2 35±2
HNO2 33±2 35±3 34±2 31±2 32±2 34±2 35±2 36±2 35±2
Vt(L) Control 1.70±0.18 1.58±0.12 1.80±0.20 1.73±0.18 1.65±0.17 1.64±0.14 1.63±0.13 1.70±0.16 1.74 ±0.16
HNO2 1.69±0.16 1.64± 0.15 1.62±0.13 1.67 ±0.13 1.53±0.10 1.61 ± 0.12 1.68±0.14 1.78±0.12 1.61 ±0.13
f Control 20±2 22±1 21±1 19±1 21±2 22±2 23±3 21±2 21±1
(breaths/min) HNO2 21±2 22±2 22±2 20±1 23±1 22±1 22±1 21±2 23±2
Abbreviations: HR, heart rate;VE minute ventilation, V tidal volume,f, breathing rate.
aThere were no statistically significant differences between control and HNO2 measurements for any parameter.
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Table 3. Cumulative symptom responses (10-point
scale) for all subjects with control air and HNO2
chamber exposures
Question Exposure status Mean value
Shortness of breath Air 0.625
HNO2 1.075
Wheeze Air 0.1
HNO2 0.125
Cough Air 0.25
HNO2 0.275
Chesttightness Air 0.25
HNO2 0.325
Skin irritation Air 0.25
HN02 0.375
Eye irritation Air 0.60
HN02 0.65
Eye tearing Air 0.225
HNO2 0.225
Throat irritation Air 0.150
HNO2 0.4
Nasal stuffiness Air 0.625
HNO2 0.75
Nasal dryness Air 0.70
HNO2 0.725
aThe aggregate score of all 10 test symptoms was
significantly higher on the HNO2 exposure than
the control days. Each symptom was assessed
just before, during, and immediately after expo-
sure. (Headache was included in the question-
naire as a negative control symptom and was not
included in this analysis.)
vitro conditions simulating low exposure to
nitrogen dioxide (less than 100 ppm),
Pryor and Lightsey (20), proposed that the
conversion of NO2 to HNO2 is initiated
according to the following reaction:
NO2 + -HC = CH-CH2--*
HNO2 + -CH-CH-CH-
which is similar to the mechanism for for-
mation ofHNO2from NO2 postulated on
the basis ofexperimental observations in
airways (7,21).
The rate of tissue absorption ofa vapor
as it is inhaled in the respiratory system is
determined by its concentration, the solu-
bility of the vapor in water, and the rate of
airflow. The effective solubility (Henry)
coefficient ofHNO2 is close to that ofsulfur
dioxide at physiologic pH (22), and increas-
es with increasing pH over the range from 2
to 6 (23). Comparisons of the respiratory
effects ofacidic gases and aerosols ofvarying
compositions indicate that the hydrogen ion
content ofthe substance is one ofthe impor-
tant determinants ofthe effect on airways. A
study ofthe effect ofinhaled acid aerosols in
asthmatics has suggested that titratable acidi-
ty, as well as the specific chemical composi-
tion and pH, are important determinants of
the potency of acid in producing effects on
lungmechanics (24).
Asthmatics were selected for the pre-
sent study because of previously demon-
strated susceptibility to airway effects of
inhaled acidic aerosol (S9. Increased sensitiv-
ity of asthmatic subjects to acidic aerosols
has not been seen in all such studies
(11,12). The duration of the exposure in
this study was three times as long as the
exposures reported by Avol et al. (11) and
Aris et al. (12), and may account for the sig-
nificant effect on lung function seen in the
present study. Bronchoconstriction was not
seen at this dose and duration, even though
forced vital capacity was reduced. Further
study will be needed to determine whether
asthmatics differ in their susceptibility to
the effects of vapor-phase HNO2 from
nonasthmatics and whether airway constric-
tion is seen at dose-duration combinations
higher than those used in this study.
In summary, when exposed for 3 hr
with intermittent, moderate exercise to 650
ppb HNO2, mildly asthmatic subjects expe-
rienced a small decrease in FVC which was
apparent within 25 min of the onset of
exposure. They also reported a slightly high-
er aggregate rate of respiratory and mucous
membrane symptoms, although at this dose
they were not able to distinguish exposure
from control days. These data suggest that
the experimental dose of HNO2 used is
slightly above butvery close to the threshold
for respiratoryeffects ofHNO2.
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